Long-term efficacy and safety of ixekizumab: 5-year analysis of the UNCOVER-3 randomized controlled trial
Journal of the American Academy of Dermatology | Dec 03, 2020
Most read this week
Journal of the American Academy of Dermatology | Dec 03, 2020